Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | +3.97% | -14.67% | +126.88% |
01:50pm | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
09/05 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+126.88% | 3.94Cr | |
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-12.15% | 2.23TCr | |
-3.44% | 2.19TCr | |
-6.22% | 1.86TCr | |
-36.52% | 1.81TCr | |
-10.09% | 1.7TCr | |
+3.33% | 1.37TCr | |
+36.58% | 1.24TCr |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Citigroup Initiates Sensei Biotherapeutics at Buy Rating